Sanofi CEO Sets Growth Target For Consumer Health Business
Executive Summary
CEO Brandicourt looks to Alan Main to lead return to mid-single-digit growth for consumer brands.
You may also be interested in...
Returns From Sanofi Consumer Expansion Could Point To More
The French pharma's strategy of driving consumer health business growth by expanding the product lineup played out during the first quarter with the launch of OTC switch Xyzal Allergy and with further integration of OTC drug and vitamin brands recently acquired from Boehringer Ingelheim.
Returns From Sanofi Consumer Expansion Could Point To More
The French pharma's strategy of driving consumer health business growth by expanding the product lineup played out during the first quarter with the launch of OTC switch Xyzal Allergy and with further integration of OTC drug and vitamin brands recently acquired from Boehringer Ingelheim.
Sanofi's Consumer Business Starts 2017 With 'Reassuring' Momentum
Sanofi consumer products head Alan Main says BI's brands will "lift Sanofi into leadership positions in attractive OTC categories, namely the vitamins and minerals supplements market, digestive products, cough and cold as well as pain medications."